Gabriele Cerrone Purchases 5,800,000 Shares of OKYO Pharma Limited (LON:OKYO) Stock

OKYO Pharma Limited (LON:OKYOGet Rating) insider Gabriele Cerrone acquired 5,800,000 shares of the business’s stock in a transaction dated Thursday, May 19th. The stock was acquired at an average cost of GBX 6 ($0.07) per share, with a total value of £348,000 ($428,994.08).

Shares of OKYO Pharma stock opened at GBX 4.50 ($0.06) on Friday. OKYO Pharma Limited has a 52-week low of GBX 4 ($0.05) and a 52-week high of GBX 9 ($0.11). The stock has a market capitalization of £61.85 million and a price-to-earnings ratio of -9.00. The company has a fifty day moving average of GBX 6.21 and a 200-day moving average of GBX 6.49. The company has a debt-to-equity ratio of 1.65, a quick ratio of 8.89 and a current ratio of 8.95.

OKYO Pharma Company Profile (Get Rating)

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.

See Also

Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.